๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans

โœ Scribed by J. Barre; G. Houin; J. P. Tillement


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
334 KB
Volume
73
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Dose-dependent pharmacokinetics of a new
โœ Hee J. Kim; So H. Kim; Sun-O. Kim; Dong-H. Lee; Hong Lim; Sung-E. Yoo; Myung G. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 2 views

## Abstract The doseโ€dependent pharmacokinetic parameters of a new neuroprotective agent for ischemiaโ€reperfusion damage, KRโ€31378, were evaluated after intravenous and oral administration, 10, 20, and 50 mg/kg, to rats. After intravenous administration of 50 mg/kg, the doseโ€normalized (10 mg/kg) A

Pharmacokinetics of iohexol, a new nonio
โœ Jerome Edelson; David Shaw; Gerard Palace ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB ๐Ÿ‘ 1 views

Sixteen healthy men received iohexol intravenously at a concentration of 346 mg of iodine/mL. Doses of 500, 750, 1000, and 1500 mg of iodine/kg of body weight were administered to four volunteers each. Neither clearance nor percent of dose excreted in the urine showed any significant correlation wit

Dose-dependent pharmacokinetics of a new
โœ Young Hoon Kim; Sun Dong Yoo; You Sun Kim; Kyung Hee Lee; Hye Suk Lee ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB ๐Ÿ‘ 2 views

## Abstract The doseโ€dependency of the pharmacokinetics of a new Na^+^/H^+^ exchanger inhibitor, KRโ€33028 was evaluated in rats after intravenous and oral administration. After intravenous administration of KRโ€33028 (1, 5, 10 and 20mg/kg doses), the systemic clearance (__Cl__) was reduced and __AUC

Dose-dependent pharmacokinetics and firs
โœ Young H. Choi; Young S. Lee; Soo H. Bae; Tae K. Kim; Bong-Y. Lee; Myung G. Lee ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 162 KB ๐Ÿ‘ 2 views

## Abstract The pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous (5, 10, 20 and 50โ€‰mg/kg) and oral (10, 20 and 50โ€‰mg/kg) administration of mirodenafil, and the firstโ€pass effect of mirodenafil after intravenous, oral, intraportal, intragastric and intrad